-
Mashup Score: 7
This editorial refers to ‘Effectiveness of aortic valve replacement in Heyde syndrome: a meta-analysis’, by L.C.M.J. Golstein et al., https://doi.org/10.1093/eu
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Update Course Rewind: 2022 Top Ten Key Takeaways - 10 month(s) ago
The 10th annual Pediatric Surgery Update Course was held as a webinar on August 30, 2022. We had a lot of lively discussion and engaging presentations on the…
Source: YouTubeCategories: Latest Headlines, PediatricsTweet-
In this video we are reviewing the #top10 key takeaways from the #updatecourse, here's #9: Updates in #management of #esophageal #stenosis Hosts:@tponsky @emencisco @BrittanyLevyMD Full ep: https://t.co/CIDlU1nScY Register for #UpdateCourse2023 on Aug29 https://t.co/K3yMgqNbg0 https://t.co/3HL7BgVrWM
-
-
Mashup Score: 0Update Course Rewind: 2022 Top Ten Key Takeaways - 10 month(s) ago
The 10th annual Pediatric Surgery Update Course was held as a webinar on August 30, 2022. We had a lot of lively discussion and engaging presentations on the…
Source: YouTubeCategories: Latest Headlines, PediatricsTweet-
In this video we are reviewing the #top10 key takeaways from the #updatecourse, here's #9: Updates in the #management of #esophageal #stenosis Host: @tponsky Full ep: https://t.co/CIDlU1nScY Register for #UpdateCourse2023 (Aug 28)👇 https://t.co/K3yMgqNbg0 https://t.co/BYdwNheknc
-
-
Mashup Score: 0Cassling Connects Cardiologists with Revolutionary AI Software - 10 month(s) ago
June 22, 2023 — Cassling has announced a partnership with the goal of benefiting cardiovascular practices throughout the United States. Cassling will act as a sales agent for EchoSolv, a revolutionary new cloud-based software from Echo IQ, an AI healthtechcompany. EchoSolv, a proprietary artificial intelligence clinical decision support platform, supports cardiology practitioners in diagnosing…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @CasslingTweets @EchoSolv The Midwest company will begin offering EchoSolv, an #ArtificialIntelligence #clinical decision support platform designed to help detect severe #aortic #stenosis, to providers throughout the country: https://t.co/1ElhwNOK11
-
-
Mashup Score: 0Major Aortopulmonary Collaterals From Coronary Arteries and Dual Left Anterior Descending Artery in an Adult With Tetralogy of Fallot - 11 month(s) ago
These clinical images show the computed tomography angiography of a patient with a large non restrictive ventricular septal defect with severe pulmonary stenosis and aortic override suggestive of tetralogy of Fallot.
Source: HMP Global Learning NetworkCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Major Aortopulmonary Collaterals From Coronary Arteries and Dual Left Anterior Descending Artery in an Adult With Tetralogy of Fallot CT angiography showed a large non restrictive ventricular septal defect with pulmonary #stenosis and #aortic override: https://t.co/xOLCzYHRik https://t.co/S5zBN0kQWS
-
-
Mashup Score: 1journey towards identification of actionable molecular pathways in calcific aortic valve stenosis - 1 year(s) ago
This editorial refers to ‘Dyslipidemia, inflammation, calcification, and adiposity in aortic stenosis: a genome-wide study’, by H.Y. Chen et al., https://doi.or
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
A new era in calcific valvular aortic stenosis genetics and a new targeted therapy on the horizon? https://t.co/4fFdrc0YVW #aortic #stenosis #gene #EHJ #editorial #cardiotwitter @ESC_Journals @escardio https://t.co/MRIefbyPJ0
-
-
Mashup Score: 2Dyslipidemia, inflammation, calcification, and adiposity in aortic stenosis: a genome-wide study - 1 year(s) ago
AbstractAims. Although highly heritable, the genetic etiology of calcific aortic stenosis (AS) remains incompletely understood. The aim of this study was to dis
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
A genome-wide study in aortic stenosis! Look at the 15 genetic loci involved in dyslipidemia, inflammation, calcification, and adiposity! #aortic #stenosis #gene https://t.co/uf3noMEI7t #ehj #cardiotwitter @ESC_Journals @escardio https://t.co/BnghFfNLy8
-
-
Mashup Score: 0Abbott Receives FDA Approval for Epic Max Tissue Valve to Treat Aortic Valve Disease - 1 year(s) ago
March 31, 2023 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Epic Max stented tissue valve to treat people with aortic regurgitation or stenosis. This device is the latest addition to Abbott’s Epic surgical valve platform which has a decades-long history of safety and strong clinical outcomes, with an optimized design to further improve valve blood…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @AbbottNews Abbott announced that the U.S. Food and Drug Administration (#FDA) has approved the company's #EpicMax stented tissue valve to treat people with #aortic #regurgitation or #stenosis: https://t.co/dEBy07lL9K
-
-
Mashup Score: 0Bioresorbable Vascular Scaffolds: A Disappearing Technology, But Should We Let It Vanish? - 1 year(s) ago
This case of a 72-year-old gentleman presenting with angina and moderate stenosis demonstrates the ability to image a target vessel non-invasively and revascularize percutaneously or surgically with bioresorbable vascular scaffolds.
Source: HMP Global Learning NetworkCategories: Cardiology News and Journals, Latest HeadlinesTweet-
This case of a 72-year-old patient presenting with angina and moderate #stenosis demonstrates the advantages of using bioresorbable vascular scaffolds to image a target vessel non-invasively and revascularize percutaneously or surgically if required. https://t.co/znNcflyr3S https://t.co/jlecRFcysl
-
-
Mashup Score: 0Bioresorbable Vascular Scaffolds: A Disappearing Technology, But Should We Let It Vanish? - 1 year(s) ago
This case of a 72-year-old gentleman presenting with angina and moderate stenosis demonstrates the ability to image a target vessel non-invasively and revascularize percutaneously or surgically with bioresorbable vascular scaffolds.
Source: HMP Global Learning NetworkCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Bioresorbable Vascular Scaffolds: A Disappearing Technology, But Should We Let It Vanish? These clinical images show the use of BVS to treat moderate #stenosis in the proximal to mid left anterior descending artery. https://t.co/C7CVm6ScTL https://t.co/R97ZENYhFi
-
Heyde syndrome: could aortic valve replacement resolve gastrointestinal bleeding? Read more on #EHJ #aortic #stenosis #gastrointestinal #bleeding @ESC_Journals @escardio #cardiotwitter #EHJ @MoritzSeiffert https://t.co/AFmPyWP1sP https://t.co/leyYMmBdtS